Cognition Therapeutics
CGTX----
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Preview: Cognition Therapeutics(CGTX) predict that the EBIT is -8.817 M (+35.99%), Beat estimate;the EPS is -0.05 (+64.29%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
TBA--
0.00B--
----
EBITExceed expectations
-0.01B35.99%
-0.01B7.08%
+0.00B28.91%
EPSExceed expectations
-0.0564.29%
-0.067551.79%
+0.017512.50%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf